Topical zinc oxide for open pilonidal sinus wounds: a randomised, double-blind, placebo-controlled multicentre trial

ISRCTN ISRCTN35311675
DOI https://doi.org/10.1186/ISRCTN35311675
Protocol serial number N/A
Sponsor Bispebjerg Hospital (Denmark)
Funder Apotekerfonden 1991, Abigo Medical AB
Submission date
20/09/2004
Registration date
29/09/2004
Last edited
25/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Magnus Ågren
Scientific

Department of Surgery K
Bispebjerg Hospital
University of Copenhagen
Bispebjerg Bakke 23
Copenhagen
DK-2400
Denmark

Phone +45 35316493
Email magnus.agren@get2net.dk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymZÅRSTUDIET
Study objectivesLocally applied zinc oxide (ZnO) may be beneficial for various types of human wounds. This randomised, double-blind, placebo-controlled multicentre trial compared the effect of topical ZnO with placebo under moist conditions on the healing of excisional wounds following surgical removal of the pilonidal sinus.
Ethics approval(s)No ethics information required at time of registration.
Health condition(s) or problem(s) studiedPilonidal excisional wound
InterventionZinc oxide and polyvinylpyrrolidone versus polyvinylpyrrolidone alone
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Topical zinc oxide
Primary outcome measure(s)

Time to wound closure in days, defined by complete coverage of the
wound with visible epithelium.

Key secondary outcome measure(s)

Secondary outcomes were:
1. Postoperative antibiotic treatment
2. Re-operations
3. Pain intensity
4. Adverse events

Tertiary outcomes were:
1. Serum-zinc levels
2. Sick leave

Completion date01/05/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration75
Key inclusion criteriaPatients, 18 years or older, with a first-episode of pilonidal abscess requiring surgery are included after giving their written informed consent.
Key exclusion criteriaPrevious pilonidal surgery, hypersensitivity to zinc, dementia, insufficiency in Danish, pregnancy or lactation.
Date of first enrolment01/02/2002
Date of final enrolment01/05/2004

Locations

Countries of recruitment

  • Denmark

Study participating centre

Department of Surgery K
Copenhagen
DK-2400
Denmark

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2006 Yes No